PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis.
Systemic sclerosis (SSc) is a chronic autoimmune disorder that can result in extensive tissue damage in the skin and, in advanced cases, internal organs. Vasculopathy, aberrant immune activation, and tissue fibrosis are three hallmarks of the disease that have been identified, with vasculopathy and...
Main Authors: | John S Cho, Terry C Fang, Taylor L Reynolds, Daniel J Sofia, Stefan Hamann, Linda C Burkly |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5019454?pdf=render |
Similar Items
-
Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling.
by: Maria Arantzazu Sanchez-Fernandez, et al.
Published: (2008-01-01) -
Study on serum PDGF-BB as biomarker for diabetic retinopathy
by: Ran Chen, et al.
Published: (2019-05-01) -
Differential Effects of Intravenous Anesthetics on PDGF-BB-Induced Vascular Smooth Muscle Cell Migration
by: Miki Iida, et al.
Published: (2014-06-01) -
Targeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver Fibrosis
by: Xingqi Wang, et al.
Published: (2016-05-01) -
Differential Expression and Bioinformatics Analysis of CircRNA in PDGF-BB-Induced Vascular Smooth Muscle Cells
by: Jiangtian Tian, et al.
Published: (2020-05-01)